No Revenues in Q4 for SQI Diagnostics | GenomeWeb

NEW YORK (GenomeWeb News) – SQI Diagnostics said today that it had no revenues for its fiscal fourth quarter.

During the year-ago period, the Canadian microarray-based diagnostics development firm recorded C$5,000 (US$5,077), it said in a regulatory filing.

Net loss for the quarter ended Sept. 30 was C$1.7 million, or C$.04 per share, compared to a loss of C$3.9 million, or C$.11 per share, a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.